BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19615965)

  • 1. Capillary electrophoresis for screening of 20S proteasome inhibitors.
    Chen W; Mou K; Xu B; Ling X; Cui J; Xu P
    Anal Biochem; 2009 Nov; 394(1):62-7. PubMed ID: 19615965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of off-line and on-line capillary electrophoresis methods for the screening and characterization of adenosine kinase inhibitors and substrates.
    Iqbal J; Burbiel JC; Müller CE
    Electrophoresis; 2006 Jun; 27(12):2505-17. PubMed ID: 16786483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
    Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
    Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status.
    Matondo M; Bousquet-Dubouch MP; Gallay N; Uttenweiler-Joseph S; Recher C; Payrastre B; Manenti S; Monsarrat B; Burlet-Schiltz O
    Leuk Res; 2010 Apr; 34(4):498-506. PubMed ID: 19811823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinyl ester-based cyclic peptide proteasome inhibitors.
    Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors.
    Kloss A; Meiners S; Ludwig A; Dahlmann B
    Cardiovasc Res; 2010 Jan; 85(2):367-75. PubMed ID: 19564153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic properties of the 20S proteasome in wheat endosperm and its biochemical characteristics after seed imbibition.
    Shi C; Rui Q; Xu LL
    Plant Biol (Stuttg); 2009 Nov; 11(6):849-58. PubMed ID: 19796362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia.
    Feng B; Zhang Y; Mu J; Ye Z; Zeng W; Qi W; Luo Z; Guo Y; Yang X; Yuan F
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):129-38. PubMed ID: 19935080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
    Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
    Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors.
    Maréchal X; Pujol A; Richy N; Genin E; Basse N; Reboud-Ravaux M; Vidal J
    Eur J Med Chem; 2012 Jun; 52():322-7. PubMed ID: 22440858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase/phosphodiesterase reactions.
    Iqbal J; Lévesque SA; Sévigny J; Müller CE
    Electrophoresis; 2008 Sep; 29(17):3685-93. PubMed ID: 18803183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
    McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
    Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of b-AP15 on the 20S proteasome.
    Huang L; Jung K; Chen CH
    Biomolecules; 2014 Oct; 4(4):931-9. PubMed ID: 25317846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20S proteasome as novel biological target for organochalcogenanes.
    Piovan L; Milani P; Silva MS; Moraes PG; Demasi M; Andrade LH
    Eur J Med Chem; 2014 Feb; 73():280-5. PubMed ID: 24463395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.
    Mou K; Xu B; Ma C; Yang X; Zou X; Lü Y; Xu P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2198-202. PubMed ID: 18280155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of aromatase inhibitors in traditional Chinese medicines by electrophoretically mediated microanalysis in a partially filled capillary.
    Zhao H; Chen Z
    J Sep Sci; 2013 Aug; 36(16):2691-7. PubMed ID: 23757179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of a ubiquitin-dependent substrate using capillary electrophoresis with dual laser-induced fluorescence.
    Lee H; Ban E; Kim EE; Yoo YS; Lee D; Song EJ
    Electrophoresis; 2014 Oct; 35(20):2978-85. PubMed ID: 25070549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel organic proteasome inhibitors identified by virtual and in vitro screening.
    Basse N; Montes M; Maréchal X; Qin L; Bouvier-Durand M; Genin E; Vidal J; Villoutreix BO; Reboud-Ravaux M
    J Med Chem; 2010 Jan; 53(1):509-13. PubMed ID: 19919035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids.
    Zhu Y; Zhu X; Wu G; Ma Y; Li Y; Zhao X; Yuan Y; Yang J; Yu S; Shao F; Li R; Ke Y; Lu A; Liu Z; Zhang L
    J Med Chem; 2010 Mar; 53(5):1990-9. PubMed ID: 20158184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.